143 related articles for article (PubMed ID: 10964076)
41. Gabapentin and lamotrigine: novel antiepileptic drugs.
Btaiche IF; Woster PS
Am J Health Syst Pharm; 1995 Jan; 52(1):61-9. PubMed ID: 12879525
[TBL] [Abstract][Full Text] [Related]
42. Gabapentin associated with aggressive behavior in pediatric patients with seizures.
Tallian KB; Nahata MC; Lo W; Tsao CY
Epilepsia; 1996 May; 37(5):501-2. PubMed ID: 8617181
[TBL] [Abstract][Full Text] [Related]
43. Antiepileptic drugs in development: prospects for the near future.
Leppik IE
Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
[TBL] [Abstract][Full Text] [Related]
44. Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study.
Lindberger M; Luhr O; Johannessen SI; Larsson S; Tomson T
Ther Drug Monit; 2003 Aug; 25(4):457-62. PubMed ID: 12883229
[TBL] [Abstract][Full Text] [Related]
45. Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice.
Luszczki JJ; Swiader M; Parada-Turska J; Czuczwar SJ
Neuropsychopharmacology; 2003 Oct; 28(10):1817-30. PubMed ID: 12865900
[TBL] [Abstract][Full Text] [Related]
46. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E
Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169
[TBL] [Abstract][Full Text] [Related]
47. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Hosford DA; Wang Y
Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
[TBL] [Abstract][Full Text] [Related]
48. Advances in the pharmacotherapy of epilepsy.
Ramsay RE
Epilepsia; 1993; 34 Suppl 5():S9-16. PubMed ID: 8339715
[TBL] [Abstract][Full Text] [Related]
49. [Current data on gabapentin].
Herranz JL
Rev Neurol; 2000 Jun; 30 Suppl 1():S125-31. PubMed ID: 10904979
[TBL] [Abstract][Full Text] [Related]
50. Sleep and EEG interictal epileptiform abnormalities in partial epilepsy.
Gigli GL; Valente M
Clin Neurophysiol; 2000 Sep; 111 Suppl 2():S60-4. PubMed ID: 10996556
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.
Johannessen SI
Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953
[TBL] [Abstract][Full Text] [Related]
52. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A
Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
[TBL] [Abstract][Full Text] [Related]
53. Gabapentin for drug-resistant partial epilepsy.
Marson AG; Kadir ZA; Hutton JL; Chadwick DW
Cochrane Database Syst Rev; 2000; (2):CD001415. PubMed ID: 10796785
[TBL] [Abstract][Full Text] [Related]
54. Gabapentin-lactam, a close analogue of the anticonvulsant gabapentin, exerts convulsant activity in amygdala kindled rats.
Potschka H; Feuerstein TJ; Löscher W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):200-5. PubMed ID: 10685877
[TBL] [Abstract][Full Text] [Related]
55. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group].
Herranz JL; Sol JM; Hernández G
Rev Neurol; 2000 Jun 16-30; 30(12):1141-5. PubMed ID: 10935239
[TBL] [Abstract][Full Text] [Related]
56. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin.
Ben-Menachem E; Persson LI; Hedner T
Epilepsy Res; 1992 Mar; 11(1):45-9. PubMed ID: 1373372
[TBL] [Abstract][Full Text] [Related]
57. Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients.
Huber B; Tomka-Hoffmeister M
Seizure; 2003 Dec; 12(8):602-3. PubMed ID: 14630502
[TBL] [Abstract][Full Text] [Related]
58. Treatment effects of gabapentin for primary insomnia.
Lo HS; Yang CM; Lo HG; Lee CY; Ting H; Tzang BS
Clin Neuropharmacol; 2010; 33(2):84-90. PubMed ID: 20124884
[TBL] [Abstract][Full Text] [Related]
59. Oral gabapentin disposition in patients with epilepsy after a high-protein meal.
Benetello P; Furlanut M; Fortunato M; Baraldo M; Pea F; Tognon A; Testa G
Epilepsia; 1997 Oct; 38(10):1140-2. PubMed ID: 9579961
[TBL] [Abstract][Full Text] [Related]
60. [Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV)].
Rajna P; Szíjártó E
Ideggyogy Sz; 2006 Sep; 59(9-10):361-72. PubMed ID: 17165379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
